Seres Therapeutics Inc (NASDAQ:MCRB)

3.64
Delayed Data
As of Jul 01
 +0.205 / +5.98%
Today’s Change
2.50
Today|||52-Week Range
23.89
-56.36%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$450.1M

Company Description

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Contact Information

Seres Therapeutics, Inc.
200 Sidney Street
Cambridge Massachusetts 02139
P:(617) 945-9626
Investor Relations:
(617) 203-3467

Employees

Shareholders

Mutual fund holders39.68%
Other institutional25.96%
Individual stakeholders24.16%

Top Executives

Eric D. ShaffPresident, Chief Executive Officer & Director
Marcus ChapmanSenior Vice President-Operations
David A. ArkowitzEVP, Chief Financial & Accounting Officer
Matthew R. HennChief Scientific Officer & Executive VP
Barbara McGovernVice President-Medical Affairs